It had been believed that 6-Shogaol could arrest the cell cycle in two types of HNSCC cells, i.e., SCC4 and SCC25, at the G2/M phase and promote apoptosis to inhibit their survival through ERK1/2 and p38 signaling pathways. The gene discussed is MAPK3; the disease is head and neck squamous cell carcinoma.